tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Minerva announces financing of up to $200M to advance roluperidone
PremiumThe FlyMinerva announces financing of up to $200M to advance roluperidone
19d ago
Minerva Neurosciences Reports Q2 2025 Financial Results
Premium
Company Announcements
Minerva Neurosciences Reports Q2 2025 Financial Results
3M ago
NERV Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
NERV Earnings Report this Week: Is It a Buy, Ahead of Earnings?
3M ago
Hold Rating for Minerva Neurosciences Amidst Uncertainty Over Roluperidone and Financial Constraints
PremiumRatingsHold Rating for Minerva Neurosciences Amidst Uncertainty Over Roluperidone and Financial Constraints
9M ago
Minerva reports Q4 EPS (56c) vs. ($1.19) last year
Premium
The Fly
Minerva reports Q4 EPS (56c) vs. ($1.19) last year
9M ago
Minerva Neurosciences Reports Positive Earnings Amid FDA Challenges
Premium
Company Announcements
Minerva Neurosciences Reports Positive Earnings Amid FDA Challenges
1y ago
NERV Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-EarningsNERV Earnings Report this Week: Is It a Buy, Ahead of Earnings?
1y ago
Minerva Neurosciences Announces Board and Audit Committee Changes
Premium
Company Announcements
Minerva Neurosciences Announces Board and Audit Committee Changes
1y ago
Minerva price target lowered to $7 from $11 at H.C. Wainwright
Premium
The Fly
Minerva price target lowered to $7 from $11 at H.C. Wainwright
2y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100